Clinical Trial Update: TGRX-326 Pharmacokinetic Food Effect Bioavailability Study [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the impact of food on the bioavailability of a drug in development for non-small cell lung cancer; the trial has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shenzhen TargetRx Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED